Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
Clinical trial NCT03782064 · TERMINATED
Trial details
- NCT number
- NCT03782064
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2021-01-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.